Alzchem Group AG Invests EUR 120 Million in Growth

Alzchem Group AG, a specialty chemicals company, has announced an investment of EUR 120 million to expand its production capacity in the sports, food, and health sectors. This strategic investment will fund the construction of a highly automated production facility for creatine and related compounds, with plans to begin operations in the latter half of 2027. The initiative is expected to generate additional annual sales in the early triple-digit million range with corresponding earnings improvements.

CEO Andreas Niedermaier highlighted the company's unique position as the sole non-Asian producer of high-purity creatine, leveraging its reputation in the premium segment with brands like Creapure® and Creavitalis®. The expansion is also driven by successful market penetration in partnerships such as the one with Ehrmann, which recently introduced a "High Protein Creatine" product line.

This expansion aligns with Alzchem's broader strategy to capitalize on new opportunities in women's health and healthy aging, further solidifying its position in niche markets.